On the inhibition of cytochrome P450 3A4 by structurally diversified flavonoids

被引:1
|
作者
Mitrasinovic, Petar M. [1 ]
机构
[1] Belgrade Inst Sci & Technol, Ctr Biophys & Chem Res, Belgrade 11060, Serbia
来源
关键词
CYP3A4; cytochrome P450; 3A4; enzyme; flavonoid; inhibition; QM/MM; SCCDFTB-D; DENSITY-FUNCTIONAL-THEORY; INTERACTION ENERGIES; TIGHT-BINDING; BASE-PAIRS; DISPERSION; CYP3A4; COMPLEXES; IMPLEMENTATION; SIMULATIONS; METABOLISM;
D O I
10.1080/07391102.2021.1932603
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cytochrome P450 3A4 (CYP3A4) is the most versatile enzyme involved in drug metabolism. The timedependent inhibition of CYP3A4 by acacetin, apigenin, chrysin, and pinocembrin was experimentally detected, but not entirely elaborated so far. Thus, a two-level QM/MM (Quantum Mechanics/Molecular Mechanics) model is developed to yield insights into the receptor-flavonoid recognition at the molecular scale. Active site residues and the flavonoid are modelled using SCC-DFTB-D (QM level), while the rest of the complex is treated using AMBER force field (MM level). QM/MM binding free energies are well correlated with experimental data, indicating the largest inhibitory effect of chrysin on enzyme activity at a submicromolar concentration. Consequently, quercetin (QUE) and flavopiridol (FLP) are observed as representative examples of structurally different flavonoids. The inhibition parameters for QUE and FLP are evaluated using the well-calibrated QM/MM strategy, thereby aiding to quantitatively conceive the functional behavior of the whole family of flavonoids. A kinetic threshold for further assessment of the drug-drug interactions underlying the time-dependent inhibition of CYP3A4 by flavonoids is explored.
引用
收藏
页码:9713 / 9723
页数:11
相关论文
共 50 条
  • [41] Concomitant use of cytochrome P450 3A4 inhibitors and simvastatin
    Bottorff, M
    AMERICAN JOURNAL OF CARDIOLOGY, 2000, 85 (08): : 1042 - 1043
  • [42] Regioselectivity preference of testosterone hydroxylation by cytochrome P450 3A4
    Yan Zhang
    Phani Morisetti
    Jeffery Kim
    Lynelle Smith
    Hai Lin
    Theoretical Chemistry Accounts, 2008, 121 : 313 - 319
  • [43] Taurine modulates catalytic activity of cytochrome P450 3A4
    Shumyantseva, V. V.
    Makhova, A. A.
    Bulko, T. V.
    Bernhardt, R.
    Kuzikov, A. V.
    Shich, E. V.
    Kukes, V. G.
    Archakov, A. I.
    BIOCHEMISTRY-MOSCOW, 2015, 80 (03) : 366 - 373
  • [44] Antiprogestin-mediated inactivation of cytochrome P450 3A4
    Jang, GR
    Benet, LZ
    PHARMACOLOGY, 1998, 56 (03) : 150 - 157
  • [45] Cytochrome P450 3A4 activity after surgical stress
    Haas, CE
    Kaufman, DC
    Jones, CE
    Burstein, AH
    Reiss, W
    CRITICAL CARE MEDICINE, 2003, 31 (05) : 1338 - 1346
  • [46] Approaches for increasing the electrocatalitic efficiency of cytochrome P450 3A4
    Shumyantseva, Victoria V.
    Koroleva, Polina I.
    Bulko, Tatiana, V
    Shkel, Tatyana, V
    Gilep, Andrei A.
    Veselovsky, Alexander V.
    BIOELECTROCHEMISTRY, 2023, 149
  • [47] Structural features of midazolam allostery by cytochrome P450 3A4
    Roberts, Arthur G.
    DRUG METABOLISM REVIEWS, 2011, 43 : 70 - 70
  • [48] Rate limiting steps in cytochrome P450 3A4 catalysis
    Krauser, JA
    Guengerich, FP
    FASEB JOURNAL, 2004, 18 (08): : C238 - C238
  • [49] Taurine modulates catalytic activity of cytochrome P450 3A4
    V. V. Shumyantseva
    A. A. Makhova
    T. V. Bulko
    R. Bernhardt
    A. V. Kuzikov
    E. V. Shich
    V. G. Kukes
    A. I. Archakov
    Biochemistry (Moscow), 2015, 80 : 366 - 373
  • [50] Cytochrome P450 3A4 drug interaction profile of tofacitinib
    Krishnaswami, Sriram
    Lamba, Manisha
    Gupta, Pankaj
    Takiya, Liza
    Wang, Ronnie
    Kaplan, Irina
    Salageanu, Joanne
    Tarabar, Sanela
    Alvey, Christine
    Ndongo, Marie-Noella
    PHARMACOTHERAPY, 2012, 32 (10): : E240 - E240